Neuralink has enrolled 21 patients in human trials of its brain-computer interface, ‘The Link,’ enabling users to control devices with their minds.
China’s brain-computer interface industry is rapidly scaling from research to commercialization, driven by strong policy support, expanding clinical trials, and growing investor interest.
Looser regulation and new investment are helping groups such as NeuroXess accelerate trials of ‘brain-computer interfaces’ ...
A global race to develop a competitive brain-computer interface is heating up between the United States and China.
China’s brain-computer interface (BCI) industry is accelerating beyond the experimental stage, positioning itself as a ...
Elon Musk has announced that Neuralink is preparing to move toward high-volume production of its brain-computer interface (BCI) devices by 2026. The update was shared through a post on Musk’s social ...
Elon Musk’s company Neuralink will start "high-volume" production of its brain implant device in 2026, according to a post on X from Musk. The Neuralink implant is designed to connect the brain to a ...
OpenAI is continuing its push into healthcare by investing in Merge Labs, a brain-computer interface startup co-founded by its CEO, Sam Altman. Merge Labs is a new competitor to Elon Musk’s Neuralink, ...
The company began building its Texas facility in 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results